A journal is retracting a paper linking radio waves from cell phone towers to pain in amputees, despite objections from the authors.
“Anthropogenic Radio-Frequency Electromagnetic Fields Elicit Neuropathic Pain in an Amputation Model,” originally published Jan. 16, 2016 in PLOS ONE, suggested that rats with injured nerves experienced pain when exposed to the type of electromagnetic radiation emitted by cell phone network towers. A press release issued by the University of Texas at Dallas (UT-Dallas) — where the corresponding author Mario Romero-Ortega and two co-first authors are based — said that this phenomenon has been reported anecdotally by people missing limbs.
But the study, especially its methodology, met with immediate criticism in the article’s comment section. PLOS ONEnoted in March 2016 that the authors had contacted the journal regarding an error in some of the exposure levels reported in the study, which journal staff were “looking into.” In December 2016, the journal told the authors it was going to retract the paper. Now, more than one year later, it finally has.
The Swedish government has terminated a four-year grant to a researcher at Uppsala University recently found guilty of misconduct — and, in a first, has also banned him from applying for grants for another two years.
A representative of the Swedish Research Council told us that it is “very rare” for the body to rescind a grant — and it has never simultaneously rescinded a grant and temporarily banned the researcher from applying for funding.
Three years after receiving a complaint about extensive plagiarism and major errors in an anti-global warming paper, Elsevier says it’s still reviewing the allegations.
Too many papers cite retracted research — even after it’s been retracted. It’s a problem. It can be especially a problem in clinical fields, where patient care is at stake. Recently, Richard Gray at La Trobe University in Australia and his colleagues examined the scope of the problem in the nursing field, noting how many systematic reviews included findings from retracted clinical trials. We spoke with Gray about their findings, published in the International Journal of Nursing Studies — and what they might mean for the safety of patients.
Retraction Watch: Retractions are a concern in any field, but as you note, when clinical practice is at stake, it can be particularly worrisome. Do you think your findings raise any potential concerns about patient safety?
Researchers are retracting a 2016 PNASpaper that described a way to create gasoline-like fuels directly from carbon dioxide in the atmosphere.
Senior author Frederick MacDonnell, a professor at the University of Texas at Arlington (UTA), told us he originally thought his team had made a preliminary breakthrough that might “solve the world’s energy problems.” Instead, he said:
I’m writing regarding a recent query from an author about citation of a retracted article. The author is currently writing up a paper where the initial investigations were at least partially inspired by a paper that has recently been retracted. The author wants to recognise the influence of that work on the new study, but also recognises that – since the paper has been retracted – it would not be appropriate simply to cite it as though it were still a published paper. This isn’t a situation we’ve come across before, and I’m not sure how best to advise the author. Is it acceptable to discuss the findings of that paper provided the text clearly mentions that the paper has since been retracted? And how should this be cited in the reference list – citation to the original paper, to the retraction notice, or not at all? As experts in this area, any guidance you could provide would be greatly appreciated.